Detalhe da pesquisa
1.
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Blood
; 138(17): 1570-1582, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424958
2.
Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.
Blood
; 136(25): 2918-2926, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603412
3.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
4.
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.
Br J Haematol
; 178(1): 81-93, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419476
5.
Hedgehog activation in CLL.
Blood
; 133(25): 2628-2630, 2019 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221789
6.
Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 14(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158929
7.
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.
Blood Adv
; 6(18): 5494-5504, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640238
8.
DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.
Sci Rep
; 11(1): 11676, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083646
9.
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients.
Clin Cancer Res
; 25(8): 2503-2512, 2019 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30373751
10.
Genome-wide promoter methylation of hairy cell leukemia.
Blood Adv
; 3(3): 384-396, 2019 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723113
11.
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival.
Oncotarget
; 6(39): 42130-49, 2015 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26517523
12.
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 15(10): 612-20.e1-5, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26233718